Overview

Phenylalanine and Its Impact on Cognition

Status:
Recruiting

Trial end date:
2022-08-01

Target enrollment:

Participant gender:

Summary

The PICO-Study is a randomized, placebo-controlled, crossover, non-inferiority trial conducted to add evidence to the current European treatment guidelines for adult patients with phenylketonuria.

Phase:

Phase 4

Details

Lead Sponsor:

University Hospital Inselspital, Berne

Collaborator:

University of Zurich